Prediction and prevention of autoimmune skin disorders

被引:40
作者
Nancy, Agmon-Levin [1 ]
Yehuda, Shoenfeld [1 ,2 ]
机构
[1] Chaim Sheba Med Ctr, Dept Med B, Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Incumbent Laura Schwarz Kip Chair Res Autoimmun D, IL-69978 Tel Aviv, Israel
关键词
Autoimmunity; Prevention; Skin diseases; Genetics; Environmental factors; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY BILIARY-CIRRHOSIS; VITAMIN-D; CUTANEOUS MANIFESTATIONS; PEMPHIGUS PATIENTS; VITILIGO PATIENTS; CELIAC-DISEASE; CTLA-4; GENE; PSORIASIS; AUTOANTIBODIES;
D O I
10.1007/s00403-008-0889-3
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Autoimmune diseases can be preceded by a symptom-free phase which is defined by the presence of autoantibodies, and may last for many years. These autoantibodies may have a high positive predictive value for disease onset, severity and organ-specific complications, especially in genetically prone individuals. Characteristic autoantibodies and susceptible genes have been identified in many autoimmune systemic and mucocutaneous diseases such as systemic lupus erythematosus, pemphigus, vitiligo, dermatitis hepretiformis and even psoriasis. Prevention of overt disease may be achieved once high-risk individuals are identified and triggering factors are avoided. Numerous environmental factors, such as vitamin D deficiency, ultraviolet light, smoking, drugs, etc., that may trigger autoimmunity have been found. Alternatively, even if the autoimmune disease cannot be prevented, it may be postponed or attenuated. Thus, although large body of evidence has accumulated on characteristic autoantibodies, susceptible genes and environmental factors, many more large scale studies are needed to assess their predictive value, the preventive measurements and the means to apply them to clinical management of healthy population and high-risk individuals.
引用
收藏
页码:57 / 64
页数:8
相关论文
共 70 条
[1]  
AHARON MA, 1988, HAREFUAH, V135, P295
[2]   Epidemiology of vitiligo and associated autoimmune diseases in caucasian probands and their families [J].
Alkhateeb, A ;
Fain, PR ;
Thody, A ;
Bennett, DC ;
Spritz, RA .
PIGMENT CELL RESEARCH, 2003, 16 (03) :208-214
[3]   Development of autoantibodies before the clinical onset of systemic lupus erythematosus [J].
Arbuckle, MR ;
McClain, MT ;
Rubertone, MV ;
Scofield, RH ;
Dennis, GJ ;
James, JA ;
Harley, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1526-1533
[4]   Vitamin D and autoimmunity: New aetiological and therapeutic considerations [J].
Arnson, Yoav ;
Amital, Howard ;
Shoenfeld, Yehuda .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) :1137-1142
[5]   Tyrosinase as an autoantigen in patients with vitiligo [J].
Baharav, E ;
Merimski, O ;
Shoenfeld, Y ;
Zigelman, R ;
Gilbrud, B ;
Yecheskel, G ;
Youinou, P ;
Fishman, P .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01) :84-88
[6]   The predictive significance of autoantibodies in organ-specific autoimmune diseases [J].
Bizzaro, Nicola .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2008, 34 (03) :326-331
[7]   Are we at a stage to predict autoimmune rheumatic diseases? [J].
Bizzaro, Nicola ;
Tozzoli, Renato ;
Shoenfeld, Yehuda .
ARTHRITIS AND RHEUMATISM, 2007, 56 (06) :1736-1744
[8]  
Blank M, 2006, CLIN EXP RHEUMATOL, V24, pS20
[9]  
Brenner S, 1999, ADV EXP MED BIOL, V455, P267
[10]   Genetics of psoriasis: Paternal inheritance and a locus on chromosome 6p [J].
Burden, AD ;
Javed, S ;
Bailey, M ;
Hodgins, M ;
Connor, M ;
Tillman, D .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (06) :958-960